OMALIZUMAB
UNII 2P471X1Z11

Substance Identification & Data

This profile provides standardized clinical and technical data for Omalizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2P471X1Z11.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 242138-07-4 and the RxNorm Concept ID (RxCUI) 302379. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2P471X1Z11

CAS Registry Number

242138-07-4

RxNorm Concept ID

302379

Detailed Substance Profile

Preferred Name

OMALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

2P471X1Z11

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C29299

National Cancer Institute reference terminology for clinical and research data.

INN ID

8039

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KK-77

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Omalizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OMALIZUMAB

OMALIZUMAB (GENETICAL RECOMBINATION)

OMALIZUMAB-IGEC

Common Names & Synonyms

GBR-310

IMMUNOGLOBULIN G (HUMAN-MOUSE MONOCLONAL E25 CLONE PSV1E26 -CHAIN ANTIHUMAN IMMUNOGLOBULIN E FC REGION), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL E25 CLONE PSVIE126 -CHAIN, DIMER

IMMUNOGLOBULIN G, ANTI-(HUMAN IMMUNOGLOBULIN E FC REGION) (HUMAN-MOUSE MONOCLONAL E25 CLONE PSVIE26 -CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL E25 CLONE PSVIE26 -CHAIN, DIMER

OMALIZUMAB [EMA EPAR]

OMALIZUMAB [INN]

OMALIZUMAB [JAN]

OMALIZUMAB [MART.]

OMALIZUMAB [MI]

OMALIZUMAB [PURPLE BOOK CDER]

OMALIZUMAB [USAN]

OMALIZUMAB [VANDF]

OMALIZUMAB [WHO-DD]

OMALIZUMAB BIOSIMILAR - GLENMARK PHARMACEUTICALS

OMALIZUMAB BIOSIMILAR - SYNERMORE

OMALIZUMAB BIOSIMILAR (CT-P39)